FibroBiologics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-4.0M | $2.3M |
| FY2023 | — | $1.3M | $9.2M |
| FY2024 | — | $2.7M | $14.0M |
| FY2025 | — | $6.2M | $4.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-4.0M | $2.3M |
| FY2023 | — | $1.3M | $9.2M |
| FY2024 | — | $2.7M | $14.0M |
| FY2025 | — | $6.2M | $4.9M |